Incyte Ventures Targeted Technology Fund
Overview
Incyte Ventures Targeted Technology Fund is an early-stage venture capital fund dedicated to advancing innovative life-science companies in the Southeastern and Southwestern United States. The fund specializes in sectors such as medical devices, biotechnology, diagnostics, and specialty pharmaceuticals, aiming to support technologies that can significantly improve medical practices and patient outcomes. The fund employs a hands-on investment approach, leveraging the management team's experience and industry relationships to add value beyond capital. This strategy focuses on minimizing regulatory and technological risks, thereby reducing the time and cost required to bring products to market. Over the years, Incyte Ventures has invested in several biotechnology companies, including Vidacare Corp., ENTrigue Surgical Inc., and ViroXis Corp., demonstrating a commitment to fostering innovation in the life sciences sector.
Investment Focus
- Innovative life-science technologies with potential for significant impact on medical practices and patient outcomes.
Portfolio Companies
Reach Incyte Ventures Targeted Technology Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Incyte Ventures Targeted Technology Fund
What sectors does Incyte Ventures Targeted Technology Fund invest in?
Incyte Ventures Targeted Technology Fund invests in Medical Devices, Diagnostics, Biotechnology and Specialty Pharmaceuticals, and is based in Texas, United States. Incyte Ventures Targeted Technology Fund is listed as a venture capital in the ConnectSafely investor database.
Which regions does Incyte Ventures Targeted Technology Fund invest in?
Incyte Ventures Targeted Technology Fund invests across United States.
What companies has Incyte Ventures Targeted Technology Fund invested in?
Incyte Ventures Targeted Technology Fund's portfolio includes Vidacare Corp., ENTrigue Surgical Inc. and ViroXis Corp..
Last updated · Source: ConnectSafely investor database